Currently holds positions in Avid Bioservices Inc and ANI Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Avid Bioservices Inc | Oct. 20, 2017 - |
Interim President, Chief Executive Officer, Director | ANI Pharmaceuticals Inc | May 11, 2020 - |
Independent Director | ANI Pharmaceuticals Inc | May 17, 2018 - May 11, 2020 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-03-22 | 2022-03-21 |
ANI Pharmaceuticals Inc
(ANIP)
|
B Purchase |
5,000
+10.3%
27.76138,794 USD |
5,000 +10.3% | 27.76 | 138,794 USD | |
2021-04-22 | 2021-04-20 |
Landec Corp
(LNDC)
|
B Purchase |
10,000
+33.3%
11.26112,600 USD |
10,000 +33.3% | 11.26 | 112,600 USD | |
2021-03-17 | 2021-03-15 |
ANI Pharmaceuticals Inc
(ANIP)
|
B Purchase |
4,000
+11.4%
32.89131,555 USD |
4,000 +11.4% | 32.89 | 131,555 USD | |
2020-11-12 | 2020-11-09 |
ANI Pharmaceuticals Inc
(ANIP)
|
B Purchase |
5,000
+16.6%
25.96129,800 USD |
5,000 +16.6% | 25.96 | 129,800 USD | |
2020-08-12 | 2020-08-10 |
ANI Pharmaceuticals Inc
(ANIP)
|
B Purchase |
3,000
+11.1%
30.8992,670 USD |
3,000 +11.1% | 30.89 | 92,670 USD | |
2020-08-12 | 2020-08-10 |
ANI Pharmaceuticals Inc
(ANIP)
|
B Purchase |
4,000
+17.3%
30.98123,920 USD |
4,000 +17.3% | 30.98 | 123,920 USD | |
2020-08-12 | 2020-08-10 |
ANI Pharmaceuticals Inc
(ANIP)
|
B Purchase |
3,000
+14.9%
30.4091,200 USD |
3,000 +14.9% | 30.40 | 91,200 USD | |
2020-03-25 | 2020-03-23 |
Avid Bioservices Inc
(CDMO)
|
B Purchase |
30,000
+inf%
3.2296,600 USD |
30,000 +inf% | 3.22 | 96,600 USD |